Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Glycopyrrolate recalled?

Yes — there is an active recall. 5 ongoing FDA recalls mention Glycopyrrolate (49 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Glycopyrrolate. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Glycopyrrolate recalls on record

none so far in 2026; 49 on record, newest first
Class II · Moderate risk

Glycopyrrolate all strengths

Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.

Terminated Labeling / mix-up Advanced Pharma Inc. D-0838-2017
Class II · Moderate risk

Glycopyrrolate USP

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3082-05 D-0253-2016
Class II · Moderate risk

Glycopyrrolate

Lack of Assurance of Sterility; all sterile human compounded drugs within expiry

Terminated Sterility / contamination JD & SN Inc., dba Moses Lake Professional Pharmacy D-0094-2016
Class II · Moderate risk

glycopyrrolate

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0046-2017
Class II · Moderate risk

glycopyrrolate

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0045-2017
Class II · Moderate risk

glycopyrrolate

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0044-2017
Class II · Moderate risk

Glycopyrrolate 0.2 mg/1 mL Susp

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1037-2015
Class II · Moderate risk

Glycopyrrolate injection

Labeling: Incorrect or missing Lot and/or Exp Date: Printing error caused an overlap in the "y" and "3" making the actual "Use By 3/2015" date appear to read "Use By8/2015".

Terminated Labeling / mix-up SCA Pharmaceuticals D-0339-2015
Class I · High risk

Glycopyrrolate

Non-Sterility: One lot of Glycopyrrolate solution for injection was found to be contaminated with Bacillus thuringiensis.

Terminated Sterility / contamination Brookfield Prescription Center Inc D-1252-2014
Class II · Moderate risk

Glycopyrrolate

Labeling: Label Mixup: GLYCOPYRROLATE, Tablet, 2 mg may have potentially been mislabeled as one of the following drugs: PARICALCITOL, Capsule, 1 mcg, NDC 00074431730, Pedigree: W002667, EXP: 6/5/2014; guaiFENesin ER, Tablet, 600 mg, NDC 63824000850, Pedigree: W003244, EXP: 6/17/2014; LACTOBACILLUS, Tablet, 0, NDC 64980012950, Pedigree: AD22865_1, EXP: 5/2/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-983-2014
Class II · Moderate risk

GLYCOPYRROLATE Tablet

Labeling: Label Mixup; GLYCOPYRROLATE Tablet, 2 mg may be potentially mislabeled as LACTOBACILLUS, Tablet, NDC 64980012950, Pedigree: W003624, EXP: 1/31/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-586-2014